Literature DB >> 26290224

Expression of soluble adenylyl cyclase in acral melanomas.

H Li1,2, S M Kim1, V Savkovic3, S A Jin1, Y D Choi3, S J Yun1.   

Abstract

Soluble adenylyl cyclase (sAC) regulates melanocytic cells, and is a diagnostic marker for pigmented skin lesions. Because only a few studies on sAC expression in acral melanomas have been performed, we investigated the histopathological significance of sAC expression in 33 cases of acral melanoma, and assessed its diagnostic value in distinguishing melanoma in situ (MIS, n = 17) from acral invasive melanomas (n = 16) and melanocytic naevi (n = 11). Acral melanomas exhibited more marked nuclear immunopositivity compared with acral melanocytic naevi. sAC expression significantly correlated with the nuclear morphology of melanocytes and melanoma cells, namely, hyperchromatic nuclei and prominent nucleoli within vesicular nuclei. sAC expression was predominantly observed in the hyperchromatic nuclei of MIS and the prominent nucleoli invasive melanomas, respectively. In vitro culture models of melanocytes and melanoma cell lines exhibited sAC staining patterns similar to those of acral melanomas. Differentiation induction showed that nuclear and nucleolar expression varied depending on cell morphology. sAC immunostaining may be useful for the differential diagnosis of acral melanocytic lesions, and sAC expressed in the nucleus and nucleolus might be related to cytological and nuclear changes associated with invasion and progression of acral melanomas.
© 2015 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26290224     DOI: 10.1111/ced.12730

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

1.  Elevated cyclic AMP levels promote BRAFCA/Pten-/- mouse melanoma growth but pCREB is negatively correlated with human melanoma progression.

Authors:  Carlos I Rodríguez; Edgardo Castro-Pérez; B Jack Longley; Vijayasaradhi Setaluri
Journal:  Cancer Lett       Date:  2017-11-24       Impact factor: 8.679

Review 2.  Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy.

Authors:  Rui Guo; Tian Liu; Marzieh Dehghan Shasaltaneh; Xuan Wang; Saber Imani; QingLian Wen
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

3.  A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivation.

Authors:  Marek M Drozdz; Ashley S Doane; Rached Alkallas; Garrett Desman; Rohan Bareja; Michael Reilly; Jakyung Bang; Maftuna Yusupova; Jaewon You; Zuhal Eraslan; Jenny Z Wang; Akanksha Verma; Kelsey Aguirre; Elsbeth Kane; Ian R Watson; Olivier Elemento; Elena Piskounova; Taha Merghoub; Jonathan H Zippin
Journal:  Cell Rep       Date:  2022-09-27       Impact factor: 9.995

Review 4.  More than just acral melanoma: the controversies of defining the disease.

Authors:  Sara S Bernardes; Ingrid Ferreira; David E Elder; Aretha B Nobre; Héctor Martínez-Said; David J Adams; Carla Daniela Robles-Espinoza; Patricia A Possik
Journal:  J Pathol Clin Res       Date:  2021-07-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.